These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20517630)

  • 1. Efficacy and safety of orally administered pilocarpine hydrochloride for patients with juvenile-onset Sjögren's syndrome.
    Tomiita M; Takei S; Kuwada N; Nonaka Y; Saito K; Shimojo N; Kohno Y
    Mod Rheumatol; 2010 Oct; 20(5):486-90. PubMed ID: 20517630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of oral pilocarpine in xerostomia and Sjögren's syndrome.
    Nusair S; Rubinow A
    Semin Arthritis Rheum; 1999 Jun; 28(6):360-7. PubMed ID: 10406404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of long-term pilocarpine due to increased muscarinic acetylcholine receptor 3 in salivary glands.
    Minagi HO; Ikai K; Araie T; Sakai M; Sakai T
    Biochem Biophys Res Commun; 2018 Sep; 503(2):1098-1102. PubMed ID: 29953856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjögren's syndrome.
    Rhodus NL
    Oral Dis; 1997 Jun; 3(2):93-8. PubMed ID: 9467349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Pilocarpine on impaired salivary secretion in patients with Sjögren's syndrome.
    Jorkjend L; Bergenholtz A; Johansson AK; Johansson A
    Swed Dent J; 2008; 32(2):49-56. PubMed ID: 18700333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled release pilocarpine buccal insert in the treatment of Sjögren's syndrome.
    Gibson J; Halliday JA; Ewert K; Robertson S
    Br Dent J; 2007 Apr; 202(7):E17; discussion 404-5. PubMed ID: 17273177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with pilocarpine hydrochloride for sicca symptoms in Sjögren's syndrome].
    Takaya M; Ichikawa Y; Yamada C; Hoshina Y; Horiki T; Uchiyama M
    Ryumachi; 1997 Jun; 37(3):453-7. PubMed ID: 9256028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic pilocarpine for treatment of xerostomia.
    Berk L
    Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1333-40. PubMed ID: 18798702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of oral pilocarpin therapy in the treatment of xerostomia and xerophthalmia in patients with primary Sjögren's syndrome].
    Solans R; Bosch JA; Selva A; Simeón CP; Fonollosa V; Vilardell M
    Med Clin (Barc); 2004 Feb; 122(7):253-5. PubMed ID: 15012873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
    Cifuentes M; Del Barrio-Díaz P; Vera-Kellet C
    Br J Dermatol; 2018 Nov; 179(5):1056-1061. PubMed ID: 29432648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new medication for treatment of dry mouth in Sjögren's syndrome.
    al-Hashimi I; Taylor SE
    Tex Dent J; 2001 Apr; 118(3):262-6. PubMed ID: 11404944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilocarpine hydrochloride for the treatment of xerostomia in patients with Sjögren's syndrome in Taiwan--a double-blind, placebo-controlled trial.
    Wu CH; Hsieh SC; Lee KL; Li KJ; Lu MC; Yu CL
    J Formos Med Assoc; 2006 Oct; 105(10):796-803. PubMed ID: 17000452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. The MGI PHARMA Sjögren's Syndrome Study Group.
    Nelson JD; Friedlaender M; Yeatts RP; Yee R; McDermott M; Orlin S; Gallagher SC; Shrotriya RC
    Adv Exp Med Biol; 1998; 438():979-83. PubMed ID: 9634998
    [No Abstract]   [Full Text] [Related]  

  • 15. Candida albicans levels in patients with Sjögren's syndrome before and after long-term use of pilocarpine hydrochloride: a pilot study.
    Rhodus NL; Liljemark W; Bloomquist C; Bereuter J
    Quintessence Int; 1998 Nov; 29(11):705-10. PubMed ID: 10200720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilocarpine treatment in a mixed cohort of xerostomic patients.
    Aframian DJ; Helcer M; Livni D; Robinson SD; Markitziu A; Nadler C
    Oral Dis; 2007 Jan; 13(1):88-92. PubMed ID: 17241436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group.
    Vivino FB; Al-Hashimi I; Khan Z; LeVeque FG; Salisbury PL; Tran-Johnson TK; Muscoplat CC; Trivedi M; Goldlust B; Gallagher SC
    Arch Intern Med; 1999 Jan; 159(2):174-81. PubMed ID: 9927101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary gland ultrasonography as a primary imaging tool for predicting efficacy of xerostomia treatment in patients with Sjögren's syndrome.
    Takagi Y; Sumi M; Nakamura H; Sato S; Kawakami A; Nakamura T
    Rheumatology (Oxford); 2016 Feb; 55(2):237-45. PubMed ID: 26338664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
    Fox RI; Konttinen Y; Fisher A
    Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.